| 000 | 01640 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518082338.0 | ||
| 264 | 0 | _c20201125 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2020.119048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhuang, Bo | |
| 245 | 0 | 0 |
_aDrug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cMar 2020 |
||
| 300 |
_a119048 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChitosan _xanalogs & derivatives |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHyaluronic Acid _xchemistry |
| 650 | 0 | 4 | _aHydrogels |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aChen, Ting | |
| 700 | 1 | _aXiao, Zhimei | |
| 700 | 1 | _aJin, Yiguang | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 577 _gp. 119048 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2020.119048 _zAvailable from publisher's website |
| 999 |
_c30557500 _d30557500 |
||